Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
ZIVO Bioscience, Inc.

ZIVO Bioscience, Inc. (ZIVOW) Stock Overview

Explore ZIVO Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ZIVOW●NASDAQ
HealthcareBiotechnology
$0.04
$0.51(92.00%)
U.S. Market opens in 10h 43m

ZIVO Bioscience, Inc. (ZIVOW)

Meyka AI Score

Z

Key Financials

Market Cap164.2K
P/E Ratio-2.34
EPS (TTM)N/A
ROE2.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.84

ZIVOW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of ZIVO Bioscience, Inc. (NASDAQ: ZIVOW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, ZIVO Bioscience, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ZIVOW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.84 for the NASDAQ listing.

Key metrics behind ZIVO Bioscience, Inc.'s NASDAQ-traded stock include a P/E ratio of -2.34 and a market capitalization of 164.2K. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZIVOW on the NASDAQ.

Price Performance (NASDAQ: ZIVOW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-78.02%
6-Month Change
-85.81%
Year-to-Date (YTD) Change
N/A
1-Year Change
-96.56%
3-Year Change
-95.00%
5-Year Change
-94.82%
All-Time (Max) Change
-94.82%

Contact Information

https://www.zivobioscience.com
248 452 9866
21 East Long Lake Road, Bloomfield Hills, MI, 48304

Company Facts

70 Employees
IPO DateDec 15, 2003
CountryUS

Frequently Asked Questions